586 related articles for article (PubMed ID: 35128572)
1. DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
Zhou Y; Zhou G; Zhang J; Xu C; Zhu F; Xu P
Eur Radiol; 2022 Jul; 32(7):5004-5015. PubMed ID: 35128572
[TBL] [Abstract][Full Text] [Related]
2. MRI-Based Radiomics Nomogram for Preoperatively Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma From Resectable Colorectal Liver Metastases.
Xu Y; Ye F; Li L; Yang Y; Ouyang J; Zhou Y; Wang S; Xie L; Zhou J; Zhao H; Zhao X
Acad Radiol; 2023 Sep; 30(9):2010-2020. PubMed ID: 37414635
[TBL] [Abstract][Full Text] [Related]
3. Radiomics signature on dynamic contrast-enhanced MR images: a potential imaging biomarker for prediction of microvascular invasion in mass-forming intrahepatic cholangiocarcinoma.
Zhou Y; Zhou G; Zhang J; Xu C; Wang X; Xu P
Eur Radiol; 2021 Sep; 31(9):6846-6855. PubMed ID: 33638019
[TBL] [Abstract][Full Text] [Related]
4. A multi-center diagnostic system for intrahepatic mass-forming cholangiocarcinoma based on preoperative MRI and clinical features.
Sheng R; Zhang Y; Wang H; Zhang W; Jin K; Sun W; Dai Y; Zhou J; Zeng M
Eur Radiol; 2024 Jan; 34(1):548-559. PubMed ID: 37552257
[TBL] [Abstract][Full Text] [Related]
5. MRI-based radiomics signature: a potential imaging biomarker for prediction of microvascular invasion in combined hepatocellular-cholangiocarcinoma.
Zhou G; Zhou Y; Xu X; Zhang J; Xu C; Xu P; Zhu F
Abdom Radiol (NY); 2024 Jan; 49(1):49-59. PubMed ID: 37831165
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Tang YY; Zhao YN; Zhang T; Chen ZY; Ma XL
World J Gastroenterol; 2021 Nov; 27(41):7173-7189. PubMed ID: 34887636
[TBL] [Abstract][Full Text] [Related]
7. Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning?
Liu X; Khalvati F; Namdar K; Fischer S; Lewis S; Taouli B; Haider MA; Jhaveri KS
Eur Radiol; 2021 Jan; 31(1):244-255. PubMed ID: 32749585
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors of microvascular invasion in patients with intrahepatic mass-forming cholangiocarcinoma based on magnetic resonance images.
Chen S; Wan L; Zhao R; Peng W; Li Z; Zou S; Zhang H
Abdom Radiol (NY); 2023 Apr; 48(4):1306-1319. PubMed ID: 36872324
[TBL] [Abstract][Full Text] [Related]
9. Optimizing CT and MRI criteria for differentiating intrahepatic mass-forming cholangiocarcinoma and hepatocellular carcinoma.
Wu H; Liang Y; Wang Z; Tan C; Yang R; Wei X; Jiang X
Acta Radiol; 2023 Mar; 64(3):926-935. PubMed ID: 35898164
[TBL] [Abstract][Full Text] [Related]
10. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.
Sammon J; Fischer S; Menezes R; Hosseini-Nik H; Lewis S; Taouli B; Jhaveri K
Cancer Imaging; 2018 Feb; 18(1):8. PubMed ID: 29486800
[TBL] [Abstract][Full Text] [Related]
11. Predicting the microvascular invasion and tumor grading of intrahepatic mass-forming cholangiocarcinoma based on magnetic resonance imaging radiomics and morphological features.
Chen S; Zhu Y; Wan L; Zou S; Zhang H
Quant Imaging Med Surg; 2023 Dec; 13(12):8079-8093. PubMed ID: 38106327
[TBL] [Abstract][Full Text] [Related]
12. Radiomics nomogram based on optimal VOI of multi-sequence MRI for predicting microvascular invasion in intrahepatic cholangiocarcinoma.
Ma X; Qian X; Wang Q; Zhang Y; Zong R; Zhang J; Qian B; Yang C; Lu X; Shi Y
Radiol Med; 2023 Nov; 128(11):1296-1309. PubMed ID: 37679641
[TBL] [Abstract][Full Text] [Related]
13. Implications of ultrasound-based deep learning model for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Chen J; Zhang W; Bao J; Wang K; Zhao Q; Zhu Y; Chen Y
Abdom Radiol (NY); 2024 Jan; 49(1):93-102. PubMed ID: 37999743
[TBL] [Abstract][Full Text] [Related]
14. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
[TBL] [Abstract][Full Text] [Related]
15. The Application Value of MRI T2
Huang F; Liu X; Liu P; Xu D; Li Z; Lin H; Xie A
Comput Math Methods Med; 2022; 2022():7099476. PubMed ID: 36203532
[TBL] [Abstract][Full Text] [Related]
16. A convenient scoring system to distinguish intrahepatic mass-forming cholangiocarcinoma from solitary colorectal liver metastasis based on magnetic resonance imaging features.
Shen K; Mo W; Wang X; Shi D; Qian W; Sun J; Yu R
Eur Radiol; 2023 Dec; 33(12):8986-8998. PubMed ID: 37392232
[TBL] [Abstract][Full Text] [Related]
17. Machine learning based on gadoxetic acid-enhanced MRI for differentiating atypical intrahepatic mass-forming cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.
Chen X; Chen Y; Chen H; Zhu J; Huang R; Xie J; Zhang T; Xie A; Li Y
Abdom Radiol (NY); 2023 Aug; 48(8):2525-2536. PubMed ID: 37169988
[TBL] [Abstract][Full Text] [Related]
18. Nomogram based on MRI for preoperative prediction of Ki-67 expression in patients with intrahepatic mass cholangiocarcinoma.
Chen X; Zhu J; Zou Z; Du M; Xie J; Ye Y; Zhang L; Li Y
Abdom Radiol (NY); 2023 Feb; 48(2):567-578. PubMed ID: 36401626
[TBL] [Abstract][Full Text] [Related]
19. Nomogram based on clinical and preoperative CT features for predicting the early recurrence of combined hepatocellular-cholangiocarcinoma: a multicenter study.
Zheng C; Gu XT; Huang XL; Wei YC; Chen L; Luo NB; Lin HS; Jin-Yuan L
Radiol Med; 2023 Dec; 128(12):1460-1471. PubMed ID: 37747668
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of combined Ki67 status prediction model for intrahepatic cholangiocarcinoma based on clinicoradiological features and MRI radiomics.
Qian X; Zhou C; Wang F; Lu X; Zhang Y; Chen L; Zeng M
Radiol Med; 2023 Mar; 128(3):274-288. PubMed ID: 36773271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
